Newest Viral Hepatitis Data From AASLD 2022 - a podcast by Clinical Care Options

from 2023-12-12T21:14:12.594308

:: ::

In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from AASLD 2022, including:

Hepatitis B
Prevention of HBV vertical transmission when HBIg is unavailable
Therapeutic vaccination for HBV cure
Antiviral therapy to prevent HCC in patients with CHB in the indeterminate phase
Hepatitis delta
HDV prevalence in ethnically diverse, urban, safety-net populations
Bulevirtide ± pegIFN-α2a for chronic HDV in the French cATU study
Bulevirtide monotherapy for patients with HDV and compensated cirrhosis in the HEP4Di study
HDV functional cure with lonafarnib-based therapy
Hepatitis C
Integrated community HCV service for PWUD: the ITTREAT study
Helios-3 study of treatment of people with HCV by specialists or nonspecialists
Risk of HCC after SVR in patients with HCV

Presenter:

Stefan Zeuzem, MD
Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Frankfurt, Germany

Follow along with the downloadable slideset at:
https://bit.ly/3FxIOwZ